Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laparoscopic and partial nephrectomy.

Andrew C Novick1

  • 1Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. novicka@ccf.org

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|September 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours.

European urology·2010
Same author

Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.

The Journal of urology·2010
Same author

Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model.

The Journal of urology·2009
Same author

Minimally invasive nephron sparing management for renal tumors in solitary kidneys.

The Journal of urology·2009
Same author

Guideline for management of the clinical T1 renal mass.

The Journal of urology·2009
Same author

Surgical resection of renal cell carcinoma after targeted therapy.

The Journal of urology·2009
Same journal

Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Claudin 18.2 Targeting: A Pan-Cancer Perspective.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Camrelizumab, a patinib and radiotherapy in locally advanced, unresectable hepatocellular carcinoma: a phase 2 study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
See all related articles

Radical nephrectomy is standard for localized kidney cancer. Laparoscopic radical nephrectomy offers equivalent survival to open surgery, while nephron-sparing surgery preserves kidney function.

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Radical nephrectomy is the standard treatment for localized renal cell carcinoma (RCC).
  • Laparoscopic radical nephrectomy has become a widely adopted standard of care for T1-3a N0 M0 RCC.
  • Nephron-sparing surgery (NSS) is indicated for localized RCC when renal function preservation is crucial or for single, small tumors.

Purpose of the Study:

  • To review the outcomes of radical nephrectomy and nephron-sparing surgery for localized renal cell carcinoma.
  • To evaluate the efficacy and safety of laparoscopic approaches for both radical and nephron-sparing nephrectomies.
  • To identify the optimal indications and challenges associated with laparoscopic NSS.

Main Methods:

  • Review of existing literature and clinical data on radical nephrectomy and NSS for localized RCC.

Related Experiment Videos

  • Comparison of intermediate-term outcomes, including cancer-free survival, between open and laparoscopic radical nephrectomy.
  • Analysis of long-term functional preservation and cancer-specific survival rates for NSS, including a review of historical data from the Cleveland Clinic.

    • Main Results:

    • Laparoscopic radical nephrectomy demonstrates equivalent cancer-free survival to open radical nephrectomy for localized RCC.
    • NSS achieves excellent technical success, with 93% long-term renal function preservation and 73% 10-year cancer-specific survival in one cohort.
    • Laparoscopic NSS is effective for small, peripheral tumors, offering faster recovery, but is associated with longer ischemia times and more complications.

    Conclusions:

    • Laparoscopic radical nephrectomy is a safe and effective standard of care for localized RCC.
    • NSS is a viable option for preserving renal function in select RCC patients, with comparable oncologic outcomes to radical nephrectomy.
    • Further development in laparoscopic techniques is needed to minimize ischemia time and complications in laparoscopic NSS.